Literature DB >> 30468907

The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.

Zhen Guo1, Youhong Wang1, Yu Zhao2, Yan Shu3, Zhaoqian Liu1, Honghao Zhou1, Hui Wang4, Wei Zhang5.   

Abstract

Jab1/CSN5 is a conserved multifunctional protein involved in ubiquitin-mediated protein degradation. Deregulation of Jab1/CSN5 can exert dramatic effects on diverse cellular functions, including DNA repair, cell cycle control, apoptosis, angiogenesis, and signal transduction, all of which are critical for tumor development. Although increasing evidence has demonstrated that Jab1/CSN5 was overexpressed in a variety of human cancers and usually correlated with poor prognosis, little was known about the underlying regulatory principles that coordinated its function. In this review, we highlight recent advances of the oncogenic role of Jab1/CSN5 and its potential as a therapeutic target for anticancer intervention.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Biomaker; Jab1/CSN5; Molecular biology; Signaling transduction; Targeted therapy; Tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 30468907     DOI: 10.1016/j.gene.2018.11.061

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

Review 1.  Jab1/Cops5: a promising target for cancer diagnosis and therapy.

Authors:  Chunjue Yuan; Dong Wang; Guohong Liu; Yunbao Pan
Journal:  Int J Clin Oncol       Date:  2021-05-21       Impact factor: 3.402

2.  Berberine diminishes cancer cell PD-L1 expression and facilitates antitumor immunity via inhibiting the deubiquitination activity of CSN5.

Authors:  Yang Liu; Xiaojia Liu; Na Zhang; Mingxiao Yin; Jingwen Dong; Qingxuan Zeng; Genxiang Mao; Danqing Song; Lu Liu; Hongbin Deng
Journal:  Acta Pharm Sin B       Date:  2020-06-30       Impact factor: 11.413

3.  Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer.

Authors:  Ying Z Mazzu; Yu-Rou Liao; Subhiksha Nandakumar; Lina E Jehane; Richard P Koche; Sai Harisha Rajanala; Ruifang Li; HuiYong Zhao; Travis A Gerke; Goutam Chakraborty; Gwo-Shu Mary Lee; Gouri J Nanjangud; Anuradha Gopalan; Yu Chen; Philip W Kantoff
Journal:  Oncogene       Date:  2021-11-20       Impact factor: 8.756

4.  Prognostic value of CSN5 in patients with digestive system cancers: a systematic review and meta-analysis.

Authors:  Yonghua Guo; Meng Gao; Ye Yao; Jinghua Li; Xi Chen; Xingxing Wang; Zhang Chen; Yufeng Yuan; Weijie Ma
Journal:  BMC Cancer       Date:  2022-07-23       Impact factor: 4.638

5.  Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.

Authors:  Qi Shen; Bin Shang; Bin Jiang; Yu Wang; Zhou Wang; Gang Chen
Journal:  Thorac Cancer       Date:  2020-02-16       Impact factor: 3.500

6.  MRPS30-DT Knockdown Inhibits Breast Cancer Progression by Targeting Jab1/Cops5.

Authors:  Balu Wu; Yunbao Pan; Guohong Liu; Tian Yang; Yanxia Jin; Fuling Zhou; Yongchang Wei
Journal:  Front Oncol       Date:  2019-11-07       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.